active surveillance

Interviews and expert commentary tagged “active surveillance” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Jelle Wesseling MD PhD; 2026 EBCC: ‘Lord’ Trial Finds Active Surveillance for Estrogen-Receptor-Positive, HER2- Negative, Grade 1–2 DCIS Just As Effective as Standard Therapy
Audio Journal of Oncology

Jelle Wesseling MD PhD; 2026 EBCC: ‘Lord’ Trial Finds Active Surveillance for Estrogen-Receptor-Positive, HER2- Negative, Grade 1–2 DCIS Just As Effective as Standard Therapy

At the 2026 EBCC, Jelle Wesseling MD PhD discusses the LORD-trial, which found active surveillance for low-risk, estrogen-receptor-positive, HER2-negative, grade 1–2 DCIS is as effective as standard therapy. The trial's reassuring findings led to early cessation of randomization, supporting de-escal

2 April 2026
10:34
Localized Prostate Cancer—New Study Findings on Active Monitoring versus Early Treatment
Audio Journal of Oncology

Localized Prostate Cancer—New Study Findings on Active Monitoring versus Early Treatment

Side effects from early treatment of low and intermediate risk prostate cancer need to be balanced agains the new finding that mortality is no different during the first ten years irrespective of the

16 September 2016
6:39
← Browse all episodes